Karin Markenroth Bloch leads the Swedish National 7T facility at Lund University. She obtained a PhD in Nuclear Physics from Chalmers University of Technology, after which she started her career in MRI at DRCMR, Copenhagen, at one of the first Nordic 3T scanners in clinical use. These early experiences stimulated her interest in leveraging the potential of high field strength in clinical applications as much as research and neuroscience. Following a career in Philips as a clinical scientist, Dr. Markenroth Bloch returned to academia to start up and, since 2016, head the Swedish National 7T facility. In this role, her ambition is to make 7T MR broadly accessible to users in a range of applications. Her personal research interests are in methods for velocity-encoded phase-contrast MRI, and their use in studying flow of blood and CSF in the brain. Dr. Markenroth Bloch is engaged in several international and local MRI communities, and in public outreach and popular science initiatives. She has been involved in the ISMRM in a range of capacities, including as a member of the Board of Trustees, the ISMRM High Field Study Group committee and the ISMRM and ESMRMB program committees. Maxime Guye, M.D., Ph.D., is a Neurologist, Professor of Biophysics at the School of Medicine, Aix-Marseille University (AMU), and in the Medical Imaging Department of the Marseille University Hospital. He is also senior consultant in the Department of Clinical Neuroscience. He is deputy director and head of the clinical site of the Centre for Magnetic Resonance in Biology and Medicine (CRMBM), jointly operated by AMU, the French National Centre for Scientific Research (CNRS) and the University Hospital System. After a fellowship in the UCL Epilepsy Imaging Group (London, UK), he started a research activity on epilepsy imaging using multimodal MRI and electrophysiology in Marseille in 2002. Since 2014 he is leading the 7T MRI facility in Marseille and is particularly involved in clinical research and applications of 7T MRI in neurological diseases. He is actively involved in the MRI community at national and international level. He was elected to the ISMRM High Field Study Group committee and was a member of the ISMRM program committee. He has been elected President of the French Society for Magnetic Resonance in Biology & Medicine and a member of the scientific committee of the French Society of Radiology. Benedikt Poser is Professor of MR Methods for Neuroscience at Maastricht University. He has a background in Physics and Business Management, and obtained a PhD in MR Physics at Radboud University Nijmegen in 2009. He gained early experience with Ultra-High Field MRI and its adaption for functional imaging at the Erwin L Hahn Institute in Essen, on one of the first human 7T systems in Europe. Following a fellowship at the University of Hawaii, he returned to Europe in 2013 for a faculty appointment at Maastricht University, where he leads the MR Methods group, and since 2020 holds a Chair within the Cognitive Neuroscience department. The central focus of his work has been the development of acquisition strategies for functional and structural MRI at UHF, and bringing parallel-transmit technologies to neuroscientific application at 7T and 9.4T. Benedikt Poser is an active member of the MRI community, with engagement in several roles in the European and International societies. Amongst other functions, he served on the ISMRM and ESMRMB program committees, and as President of the ESMRMB. Together with the co-editors of this book he also enjoyed a fruitful and rewarding time on the ISMRM High Field Study Group committee.

Select Guide Rating

• Part 1: Benefits of Ultra-High Field1. The way back and ahead: MR physics at Ultra-High Field2. Translating UHF advances to lower field strengthPart 2: Acquisition at Ultra-High Field: practical considerations3. Practical solutions to practical constraints: Making things work at ultra-high field4. Practical considerations on ultra-high field safety5. Bioeffects, patience experience and occupational safetyPart 3: Ultra-High Field Challenges and Technical Solutions6. B0 inhomogeneity: Causes and coping strategies7. B1 inhomogeneity: Physics background, RF pulse design and parallel transmission8. RF coils for ultra-high field neuroimaging9. Parallel imaging and reconstruction techniques10. Motion correctionPart 4: Ultra-high field Structural Imaging: Techniques for neuroanatomy11. High-resolution T1-weighted and T2-weighted anatomical imaging12. Brain segmentation at ultra-high field: challenges, opportunities and unmet needs13. Phase imaging: Susceptibility-weighted imaging and Quantitative Susceptibility Mapping14. Quantitative MRI and multi-parametric mappingPart 5: Ultra-high field Structural Imaging: Zooming in on the brain15. Cerebellar imaging16. Ultra-high field imaging of the medial temporal lobe17. Imaging of the deep gray matter18. Brain stem imaging19. Spinal Cord ImagingPart 6: Diffusion and Perfusion imaging at Ultra-High Field20. Diffusion weighted magnetic resonance at ultra-high field21. Ultra-high Field Brain Perfusion MRIPart 7: Ultra-High Field Functional Imaging22. BOLD fMRI: physiology and acquisition strategies23. Sequences and contrasts for non-BOLD fMRI24. Laminar and columnar imaging at UHF: considerations for mesoscopic scale imaging with fMRI25. The power of gray-matter optimized fMRI at UHF for cognitive neurosciencePart 8: Techniques for Ultra-High Field Metabolic Imaging and Spectroscopy26. MR Spectroscopy and spectroscopic imaging27. Imaging with X-nuclei28. Chemical Exchange Saturation Transfer MRI in the human brain at ultra-high fieldsPart 9: Benefits of Ultra-High Field in Clinical Applications29. Epilepsy30. Multiple sclerosis31. Neurovascular diseases32. Neurodegenerative diseases33. Parkinson’s disease and Parkinson-plus syndromes34. Alzheimer's disease and ageing35. Oncological applications36. Psychiatric applications at UHFPart 10: New Horizons37. Human MR at extremely high field strengths

Karin Markenroth Bloch leads the Swedish National 7T facility at Lund University. She obtained a PhD in Nuclear Physics from Chalmers University of Technology, after which she started her career in MRI at DRCMR, Copenhagen, at one of the first Nordic 3T scanners in clinical use. These early experiences stimulated her interest in leveraging the potential of high field strength in clinical applications as much as research and neuroscience. Following a career in Philips as a clinical scientist, Dr. Markenroth Bloch returned to academia to start up and, since 2016, head the Swedish National 7T facility. In this role, her ambition is to make 7T MR broadly accessible to users in a range of applications. Her personal research interests are in methods for velocity-encoded phase-contrast MRI, and their use in studying flow of blood and CSF in the brain. Dr. Markenroth Bloch is engaged in several international and local MRI communities, and in public outreach and popular science initiatives. She has been involved in the ISMRM in a range of capacities, including as a member of the Board of Trustees, the ISMRM High Field Study Group committee and the ISMRM and ESMRMB program committees. Maxime Guye, M.D., Ph.D., is a Neurologist, Professor of Biophysics at the School of Medicine, Aix-Marseille University (AMU), and in the Medical Imaging Department of the Marseille University Hospital. He is also senior consultant in the Department of Clinical Neuroscience. He is deputy director and head of the clinical site of the Centre for Magnetic Resonance in Biology and Medicine (CRMBM), jointly operated by AMU, the French National Centre for Scientific Research (CNRS) and the University Hospital System. After a fellowship in the UCL Epilepsy Imaging Group (London, UK), he started a research activity on epilepsy imaging using multimodal MRI and electrophysiology in Marseille in 2002. Since 2014 he is leading the 7T MRI facility in Marseille and is particularly involved in clinical research and applications of 7T MRI in neurological diseases. He is actively involved in the MRI community at national and international level. He was elected to the ISMRM High Field Study Group committee and was a member of the ISMRM program committee. He has been elected President of the French Society for Magnetic Resonance in Biology & Medicine and a member of the scientific committee of the French Society of Radiology. Benedikt Poser is Professor of MR Methods for Neuroscience at Maastricht University. He has a background in Physics and Business Management, and obtained a PhD in MR Physics at Radboud University Nijmegen in 2009. He gained early experience with Ultra-High Field MRI and its adaption for functional imaging at the Erwin L Hahn Institute in Essen, on one of the first human 7T systems in Europe. Following a fellowship at the University of Hawaii, he returned to Europe in 2013 for a faculty appointment at Maastricht University, where he leads the MR Methods group, and since 2020 holds a Chair within the Cognitive Neuroscience department. The central focus of his work has been the development of acquisition strategies for functional and structural MRI at UHF, and bringing parallel-transmit technologies to neuroscientific application at 7T and 9.4T. Benedikt Poser is an active member of the MRI community, with engagement in several roles in the European and International societies. Amongst other functions, he served on the ISMRM and ESMRMB program committees, and as President of the ESMRMB. Together with the co-editors of this book he also enjoyed a fruitful and rewarding time on the ISMRM High Field Study Group committee.

Select Guide Rating

• Part 1: Benefits of Ultra-High Field1. The way back and ahead: MR physics at Ultra-High Field2. Translating UHF advances to lower field strengthPart 2: Acquisition at Ultra-High Field: practical considerations3. Practical solutions to practical constraints: Making things work at ultra-high field4. Practical considerations on ultra-high field safety5. Bioeffects, patience experience and occupational safetyPart 3: Ultra-High Field Challenges and Technical Solutions6. B0 inhomogeneity: Causes and coping strategies7. B1 inhomogeneity: Physics background, RF pulse design and parallel transmission8. RF coils for ultra-high field neuroimaging9. Parallel imaging and reconstruction techniques10. Motion correctionPart 4: Ultra-high field Structural Imaging: Techniques for neuroanatomy11. High-resolution T1-weighted and T2-weighted anatomical imaging12. Brain segmentation at ultra-high field: challenges, opportunities and unmet needs13. Phase imaging: Susceptibility-weighted imaging and Quantitative Susceptibility Mapping14. Quantitative MRI and multi-parametric mappingPart 5: Ultra-high field Structural Imaging: Zooming in on the brain15. Cerebellar imaging16. Ultra-high field imaging of the medial temporal lobe17. Imaging of the deep gray matter18. Brain stem imaging19. Spinal Cord ImagingPart 6: Diffusion and Perfusion imaging at Ultra-High Field20. Diffusion weighted magnetic resonance at ultra-high field21. Ultra-high Field Brain Perfusion MRIPart 7: Ultra-High Field Functional Imaging22. BOLD fMRI: physiology and acquisition strategies23. Sequences and contrasts for non-BOLD fMRI24. Laminar and columnar imaging at UHF: considerations for mesoscopic scale imaging with fMRI25. The power of gray-matter optimized fMRI at UHF for cognitive neurosciencePart 8: Techniques for Ultra-High Field Metabolic Imaging and Spectroscopy26. MR Spectroscopy and spectroscopic imaging27. Imaging with X-nuclei28. Chemical Exchange Saturation Transfer MRI in the human brain at ultra-high fieldsPart 9: Benefits of Ultra-High Field in Clinical Applications29. Epilepsy30. Multiple sclerosis31. Neurovascular diseases32. Neurodegenerative diseases33. Parkinson’s disease and Parkinson-plus syndromes34. Alzheimer's disease and ageing35. Oncological applications36. Psychiatric applications at UHFPart 10: New Horizons37. Human MR at extremely high field strengths

Karin Markenroth Bloch leads the Swedish National 7T facility at Lund University. She obtained a PhD in Nuclear Physics from Chalmers University of Technology, after which she started her career in MRI at DRCMR, Copenhagen, at one of the first Nordic 3T scanners in clinical use. These early experiences stimulated her interest in leveraging the potential of high field strength in clinical applications as much as research and neuroscience. Following a career in Philips as a clinical scientist, Dr. Markenroth Bloch returned to academia to start up and, since 2016, head the Swedish National 7T facility. In this role, her ambition is to make 7T MR broadly accessible to users in a range of applications. Her personal research interests are in methods for velocity-encoded phase-contrast MRI, and their use in studying flow of blood and CSF in the brain. Dr. Markenroth Bloch is engaged in several international and local MRI communities, and in public outreach and popular science initiatives. She has been involved in the ISMRM in a range of capacities, including as a member of the Board of Trustees, the ISMRM High Field Study Group committee and the ISMRM and ESMRMB program committees. Maxime Guye, M.D., Ph.D., is a Neurologist, Professor of Biophysics at the School of Medicine, Aix-Marseille University (AMU), and in the Medical Imaging Department of the Marseille University Hospital. He is also senior consultant in the Department of Clinical Neuroscience. He is deputy director and head of the clinical site of the Centre for Magnetic Resonance in Biology and Medicine (CRMBM), jointly operated by AMU, the French National Centre for Scientific Research (CNRS) and the University Hospital System. After a fellowship in the UCL Epilepsy Imaging Group (London, UK), he started a research activity on epilepsy imaging using multimodal MRI and electrophysiology in Marseille in 2002. Since 2014 he is leading the 7T MRI facility in Marseille and is particularly involved in clinical research and applications of 7T MRI in neurological diseases. He is actively involved in the MRI community at national and international level. He was elected to the ISMRM High Field Study Group committee and was a member of the ISMRM program committee. He has been elected President of the French Society for Magnetic Resonance in Biology & Medicine and a member of the scientific committee of the French Society of Radiology. Benedikt Poser is Professor of MR Methods for Neuroscience at Maastricht University. He has a background in Physics and Business Management, and obtained a PhD in MR Physics at Radboud University Nijmegen in 2009. He gained early experience with Ultra-High Field MRI and its adaption for functional imaging at the Erwin L Hahn Institute in Essen, on one of the first human 7T systems in Europe. Following a fellowship at the University of Hawaii, he returned to Europe in 2013 for a faculty appointment at Maastricht University, where he leads the MR Methods group, and since 2020 holds a Chair within the Cognitive Neuroscience department. The central focus of his work has been the development of acquisition strategies for functional and structural MRI at UHF, and bringing parallel-transmit technologies to neuroscientific application at 7T and 9.4T. Benedikt Poser is an active member of the MRI community, with engagement in several roles in the European and International societies. Amongst other functions, he served on the ISMRM and ESMRMB program committees, and as President of the ESMRMB. Together with the co-editors of this book he also enjoyed a fruitful and rewarding time on the ISMRM High Field Study Group committee.

Select Guide Rating

• Part 1: Benefits of Ultra-High Field1. The way back and ahead: MR physics at Ultra-High Field2. Translating UHF advances to lower field strengthPart 2: Acquisition at Ultra-High Field: practical considerations3. Practical solutions to practical constraints: Making things work at ultra-high field4. Practical considerations on ultra-high field safety5. Bioeffects, patience experience and occupational safetyPart 3: Ultra-High Field Challenges and Technical Solutions6. B0 inhomogeneity: Causes and coping strategies7. B1 inhomogeneity: Physics background, RF pulse design and parallel transmission8. RF coils for ultra-high field neuroimaging9. Parallel imaging and reconstruction techniques10. Motion correctionPart 4: Ultra-high field Structural Imaging: Techniques for neuroanatomy11. High-resolution T1-weighted and T2-weighted anatomical imaging12. Brain segmentation at ultra-high field: challenges, opportunities and unmet needs13. Phase imaging: Susceptibility-weighted imaging and Quantitative Susceptibility Mapping14. Quantitative MRI and multi-parametric mappingPart 5: Ultra-high field Structural Imaging: Zooming in on the brain15. Cerebellar imaging16. Ultra-high field imaging of the medial temporal lobe17. Imaging of the deep gray matter18. Brain stem imaging19. Spinal Cord ImagingPart 6: Diffusion and Perfusion imaging at Ultra-High Field20. Diffusion weighted magnetic resonance at ultra-high field21. Ultra-high Field Brain Perfusion MRIPart 7: Ultra-High Field Functional Imaging22. BOLD fMRI: physiology and acquisition strategies23. Sequences and contrasts for non-BOLD fMRI24. Laminar and columnar imaging at UHF: considerations for mesoscopic scale imaging with fMRI25. The power of gray-matter optimized fMRI at UHF for cognitive neurosciencePart 8: Techniques for Ultra-High Field Metabolic Imaging and Spectroscopy26. MR Spectroscopy and spectroscopic imaging27. Imaging with X-nuclei28. Chemical Exchange Saturation Transfer MRI in the human brain at ultra-high fieldsPart 9: Benefits of Ultra-High Field in Clinical Applications29. Epilepsy30. Multiple sclerosis31. Neurovascular diseases32. Neurodegenerative diseases33. Parkinson’s disease and Parkinson-plus syndromes34. Alzheimer's disease and ageing35. Oncological applications36. Psychiatric applications at UHFPart 10: New Horizons37. Human MR at extremely high field strengths